Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies
With the growing demand for the development of intranasal (IN) products, such as nasal vaccines, which has been especially highlighted during the COVID-19 pandemic, the lack of novel technologies to accurately test the safety and effectiveness of IN products in vitro so that they can be delivered pr...
Main Authors: | Muhammad Usman Khan, Xinyu Cai, Zhiwei Shen, Taye Mekonnen, Agisilaos Kourmatzis, Shaokoon Cheng, Hanieh Gholizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1557 |
Similar Items
-
Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development
by: Hanieh Gholizadeh, et al.
Published: (2022-04-01) -
Prosthetic rehabilitation of large nasal septal defect with an intranasal stent: A clinical report
by: Mukesh Kumar Goyal, et al.
Published: (2011-01-01) -
Editorial: Intranasal Drug Delivery: Challenges and Opportunities
by: Ana Fortuna, et al.
Published: (2022-03-01) -
The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing
by: Eugen Viktor Koch, et al.
Published: (2023-10-01) -
Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
by: Oxana Semyachkina-Glushkovskaya, et al.
Published: (2022-12-01)